Ironwood Pharmaceuticals | IRWD - Stammkapital

Aktienkurs
3.93
Täglich Wechseln
0.14 3.69%
Monatlich
23.20%
Jährlich
342.32%
Q2 Prognose
3.85




Stammkapital Veränderung Datum
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Almirall EUR 214.79M 0 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Astellas Pharma JPY 1.79B 195K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Coherus Biosciences USD 121.16M 4.92M 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
MacroGenics USD 63.32M 60K 2025-12
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 41.12M 1.85M 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12